These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2367321)

  • 1. Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data.
    Macheras P; Reppas C; Dressman JB
    Pharm Res; 1990 May; 7(5):518-22. PubMed ID: 2367321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.
    Hörter D; Dressman JB
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):75-87. PubMed ID: 11259834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative derivation for the gastrointestinal absorption residence time.
    Chiou WL; Chen TM; Choo YS; Abdel-Hameed MH
    J Pharm Sci; 1992 May; 81(5):486-7. PubMed ID: 1403687
    [No Abstract]   [Full Text] [Related]  

  • 5. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.
    Kalampokis A; Argyrakis P; Macheras P
    Pharm Res; 1999 Nov; 16(11):1764-9. PubMed ID: 10571284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.
    Sinko PJ; Leesman GD; Amidon GL
    Pharm Res; 1991 Aug; 8(8):979-88. PubMed ID: 1924168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the fractional absorption of D-xylose by analysis of gastrointestinal disposition after oral administration in rats.
    Yuasa H; Kuno C; Watanabe J
    Biol Pharm Bull; 1996 Apr; 19(4):604-7. PubMed ID: 8860967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A compartmental absorption and transit model for estimating oral drug absorption.
    Yu LX; Amidon GL
    Int J Pharm; 1999 Sep; 186(2):119-25. PubMed ID: 10486429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal transit and drug absorption.
    Kimura T; Higaki K
    Biol Pharm Bull; 2002 Feb; 25(2):149-64. PubMed ID: 11853157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.
    Abuhelwa AY; Mudge S; Hayes D; Upton RN; Foster DJ
    Pharm Res; 2016 Jul; 33(7):1782-94. PubMed ID: 27119846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1994 May; 44(5):679-82. PubMed ID: 8024648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters.
    Ishii K; Katayama Y; Itai S; Ito Y; Hayashi H
    Biol Pharm Bull; 1995 Jun; 18(6):882-6. PubMed ID: 7550125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental difference in transmucosal fluid movement and glucose effect on drug absorption from rat gastrointestinal tract.
    Kitazawa S; Ito H; Sezaki H
    Chem Pharm Bull (Tokyo); 1977 Jan; 25(1):19-28. PubMed ID: 852082
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
    Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
    J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologic model for simulating gastrointestinal flow and drug absorption in rats.
    Willmann S; Schmitt W; Keldenich J; Dressman JB
    Pharm Res; 2003 Nov; 20(11):1766-71. PubMed ID: 14661920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug solubility in luminal fluids from different regions of the small and large intestine of humans.
    Fadda HM; Sousa T; Carlsson AS; Abrahamsson B; Williams JG; Kumar D; Basit AW
    Mol Pharm; 2010 Oct; 7(5):1527-32. PubMed ID: 20726533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical model for dose-dependent drug absorption.
    Dressman JB; Fleisher D; Amidon GL
    J Pharm Sci; 1984 Sep; 73(9):1274-9. PubMed ID: 6548523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.